IMUNON INC (IMNN) Stock Income Statement
NASDAQ:IMNN - Nasdaq - US15117N6022 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 500.00K | 500.00K | 500.00K | 500.00K | |||
| Operating Expenses | 21.03M | 25.42M | 21.51M | 18.99M | 21.07M | |||
| Research and Development | 11.29M | 11.73M | 10.62M | 11.34M | 13.07M | |||
| Selling, General, and Administrative Expenses | 9.74M | 13.69M | 10.89M | 7.64M | 8.00M | |||
| Operating Income | -21.03M | -24.92M | -21.01M | -18.49M | -20.57M | |||
| Interest Income/Expense | 960.60K | -4.58M | -560.00K | -1.17M | -1.29M | |||
| Other Income/Expense | -396.30K | 5.40M | 1.62M | -1.30M | 3.19M | |||
| Non Recurring Items | -329.20K | -13.37M | -2.21M | -2.37M | 0.00 | |||
| Income Before Taxes | -20.80M | -37.47M | -22.15M | -23.33M | -18.67M | |||
| Income Tax | -1.28M | -1.57M | -1.38M | -1.85M | -1.82M | |||
| Net Income | -19.52M | -35.90M | -20.77M | -21.48M | -16.85M | |||
| EBITDA | -20.78M | -24.19M | -20.31M | -17.75M | -19.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.16 | -5.03 | -3.83 | -10.08 | -11.54 | |||
| Non GAAP EPS | -2.18 | -5.17 | N/A | -10.05 | -11.10 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -7180.00% | -4154.00% | -4296.00% | -3370.00% | |||
| Operating Profit Margin | N/A | -4984.00% | -4202.00% | -3698.00% | -4114.00% | |||
All data in USD